sales
Deloitte acquires Iperion Life Sciences Consultancy
May 7, 2021Medical Communications marketing, sales
Deloitte have announced the acquisition of Iperion Life Sciences Consultancy, a globally-operating firm working to support life sciences companies and …
Novartis CEO sets aside $700 million to settle bribery lawsuit
July 18, 2019Business Services, Sales and Marketing Novartis, bribery, lawsuit, pharma, sales
Vas Narasimhan, Novartis’ CEO, has set aside $700 million to settle a bribery lawsuit in the United States. Speaking in …
EU pharmaceutical industry lost €16.5 billion in sales as staff shift to patent infringing firms
June 19, 2019Research and Development EU, counterfeit, generics, pharma, sales
A report from the European Union Intellectual Property Office (EUIPO) has said ‘counterfeit’ drugs cost the EU pharmaceutical industry €16.5 …
GSK to reintroduce bonuses for sales reps
May 24, 2019Medical Communications GSK, US, oncology, pharma, sales, sales reps, scandal
British multinational GlaxoSmithKline said on Thursday that it would reintroduce performance-based bonuses for some sales reps in some countries. The …
Gilead to lay off one fifth of sales force
April 11, 2019Sales and Marketing Gilead, Jobs, Letairis, Ranexa, redundancy, sales
Gilead Sciences is preparing to lay off around a fifth of its salesforce in anticipation for the expiry of patents …
Indian government set to colour code generic medicines
March 4, 2019Sales and Marketing India, Indian health, costs, generic medicines, pricing, sales
As part of an effort to promote low cost medicines, the Indian government has announced plans to colour code generic …
Stripper-turned-Insys sales rep gave lap dance to persuade doctor to prescribe fentanyl
January 31, 2019Medical Communications Sunrise Lee, US, chicago, corruption, insys, sales
A pharmaceutical executive working for Insys therapeutics has been accused of giving a doctor a lap dance in an effort …
Pfizer announces new UK Managing Director
December 10, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ben Osborne, EU, Leeds, Pfizer, sales
New York City-based multinational Pfizer has announced the appointment of Ben Osborn to the role of managing Director in the …
Bristol Myers Squibb announces departure of Chief Commercial Officer
July 24, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myers Squibb, bristol myers squibb, commerical executive, marketing, sales
Bristol Myers Squibb has announced that Executive Vice President and Chief Commercial Officer, Murdo Gordon, who has been with the …
Shire completes Baxalta takeover
June 3, 2016Medical Communications, Research and Development, Sales and Marketing Baxalta, Shire, deal, merger and acquisition, revenue, sales
UK drugmaker Shire (LSE: SHP) on Friday announced the completion of merger with rare disease specialist Baxalta (NYSE: BXLT). The …
AstraZeneca licenses gout drug Zurampic to Grünenthal in Europe and Latin America
June 2, 2016Business Services, Manufacturing and Production, Sales and Marketing AstraZeneca, Grunenthal, Licencing, Zurampic, gout, sales
UK drugmaker AstraZeneca (LSE: AZN) on Thursday said it has entered into a licensing agreement worth up to $230 million …
Genmab receives milestone payment for first Darzalex sale in Europe
May 31, 2016Manufacturing and Production, Sales and Marketing EU, FDA, Janssen, commercial, commercialised, daratumumab, darzalex, genman, multiple myeloma, sale, sales
Genmab (NASDAQ: GEN) has announced that the company is set to receive a milestone payment of $30 million from its …
Merck & Co Q1 sales hurt by generics, currency impact
May 6, 2016Medical Communications, Sales and Marketing Financial, Merck & Co, Q1, Revenye, earnings, results, sales
US pharma major Merck & Co (NYSE: MRK) posted a drop in first-quarter sales impacted the launch of generic competition …
Pfizer revenue jumps 20%; ups FY16 outlook
May 4, 2016Research and Development, Sales and Marketing Pfizer, Q1, earnings, results, revenue, sales
US pharma giant Pfizer (NYSE: PFE) reported a 20% jump in first-quarter revenue boosted by performance of its new cancer …
